Janux Therapeutics Inc (JANX)
61.12
-3.66
(-5.65%)
USD |
NASDAQ |
May 06, 09:35
Janux Therapeutics Revenue (TTM): 8.083M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.083M |
| September 30, 2023 | 8.467M |
| June 30, 2023 | 7.763M |
| March 31, 2023 | 9.071M |
| December 31, 2022 | 8.612M |
| Date | Value |
|---|---|
| September 30, 2022 | 7.383M |
| June 30, 2022 | 6.729M |
| March 31, 2022 | 4.846M |
| December 31, 2021 | 3.637M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
3.637M
Minimum
Dec 2021
9.071M
Maximum
Mar 2023
7.177M
Average
7.763M
Median
Jun 2023
Revenue (TTM) Benchmarks
| Viking Therapeutics Inc | -- |
| Equillium Inc | 36.08M |
| Minerva Neurosciences Inc | -- |
| Arvinas Inc | 78.50M |
| Calidi Biotherapeutics Inc | -- |